Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
NCT06197308
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Primary Sclerosing Cholangitis
Interventions
DRUG:
oral vancomycin and oral amoxicillin
Sponsor
University of Minnesota